Protalix Biotherapeutics, Inc. (PLX)
1.76
-0.03
(-1.68%)
USD |
NYAM |
Dec 30, 15:10
Protalix Biotherapeutics Market Cap: 141.54M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| PAVmed, Inc. | 6.896M |
| Denali Therapeutics, Inc. | 2.573B |
| AIM ImmunoTech, Inc. | 0.9552M |
| Perspective Therapeutics, Inc. | 202.94M |
| Armata Pharmaceuticals, Inc. | 227.86M |
Market Cap Related Metrics
| PE Ratio | 25.32 |
| PS Ratio | 2.238 |
| Price to Book Value | 2.675 |
| Price | 1.76 |
| Earnings Yield | 3.95% |
| Operating PE Ratio | 21.74 |
| Normalized PE Ratio | 25.32 |